肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

抗肿瘤药物临床试验技术指导原则

2012-05-15 国家药品监督管理局药品审评中心（CDE）

肿瘤

抗肿瘤药物临床试验技术指导原则

中文标题：

抗肿瘤药物临床试验技术指导原则

发布机构：

国家药品监督管理局药品审评中心（CDE）

发布日期：

2012-05-15

简要介绍：

抗肿瘤药物临床试验技术指导原则

相关资料下载：
[AttachmentFileName(sort=100, fileName=抗肿瘤药物临床试验技术指导原则)] GetToolGuiderByIdResponse(projectId=1, id=b8e011c0018169d3, title=抗肿瘤药物临床试验技术指导原则, enTitle=, guiderFrom=, authorId=null, author=, summary=抗肿瘤药物临床试验技术指导原则, cover=, journalId=null, articlesId=null, associationId=1936, associationName=国家药品监督管理局药品审评中心（CDE）, associationIntro=国家药品监督管理局药品审评中心（CDE）, copyright=0, guiderPublishedTime=Tue May 15 00:00:00 CST 2012, originalUrl=, linkOutUrl=, content=抗肿瘤药物临床试验技术指导原则, tagList=[TagDto(tagId=119, tagName=肿瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=67, categoryName=研究设计与统计, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6532, appHits=59, showAppHits=0, pcHits=2502, showPcHits=6067, likes=54, shares=4, comments=4, approvalStatus=1, publishedTime=Thu Oct 31 05:30:56 CST 2019, publishedTimeString=2012-05-15, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Thu Oct 31 05:30:56 CST 2019, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 01:01:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=抗肿瘤药物临床试验技术指导原则)])
抗肿瘤药物临床试验技术指导原则
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1194163, encodeId=73b91194163cb, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33d71335965, createdName=youe520, createdTime=Wed Feb 16 21:55:18 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011421, encodeId=315e10114216c, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2af5584843, createdName=ms9000001132151029, createdTime=Wed Aug 25 17:07:18 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964158, encodeId=430d96415893, content=怎么增加积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab015472613, createdName=ms3000000373492752, createdTime=Mon May 10 01:12:50 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
    2022-02-16 youe520

    谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1194163, encodeId=73b91194163cb, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33d71335965, createdName=youe520, createdTime=Wed Feb 16 21:55:18 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011421, encodeId=315e10114216c, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2af5584843, createdName=ms9000001132151029, createdTime=Wed Aug 25 17:07:18 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964158, encodeId=430d96415893, content=怎么增加积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab015472613, createdName=ms3000000373492752, createdTime=Mon May 10 01:12:50 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
    2021-08-25 ms9000001132151029

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1194163, encodeId=73b91194163cb, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33d71335965, createdName=youe520, createdTime=Wed Feb 16 21:55:18 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011421, encodeId=315e10114216c, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2af5584843, createdName=ms9000001132151029, createdTime=Wed Aug 25 17:07:18 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964158, encodeId=430d96415893, content=怎么增加积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab015472613, createdName=ms3000000373492752, createdTime=Mon May 10 01:12:50 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
    2021-05-10 ms3000000373492752

    怎么增加积分

    0

相关指南

肿瘤个体化治疗相关基因突变检测试剂技术审查指导原则(2014年第2号)

国家药品监督管理局药品审评中心（CDE） · 2019-10-30

经导管动脉灌注化疗药物应用原则—中国肿瘤介入专家共识

中国抗癌协会肿瘤介入专家委员会 · 2017-11-30

中国肿瘤热疗临床应用指南（2017.V1.1）

中日医学科技交流协会热疗专业委员会 · 2017-04-20

肿瘤患者CT增强扫描安全管理专家共识

中国抗癌协会肿瘤影像专业委员会 · 2017-06-30

计算机辅助联合吲哚菁绿分子荧光影像技术在 肝脏肿瘤诊断和手术导航中的应用专家共识

中华医学会数字医学分会 · 2017-06-28

肿瘤深部热疗和全身热疗技术 临床应用质量控制指标（2017）

中华人民共和国国家卫生和计划生育委员会(NHFPC,National Health and Family Planning Commission of China) · 2017-02-14